THE IMPACT OF COGNITIVE BEHAVIORAL THERAPY ON OCD’S PATIENTS
DOI:
https://doi.org/10.31435/ijitss.3(47).2025.4061Keywords:
Obsessive-Compulsive Disorder (OCD), Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP), Mental Health Disorders, Treatment EfficacyAbstract
Introduction: Cognitive Behavioral Therapy (CBT) is a well-established, empirically supported intervention for Obsessive-Compulsive Disorder (OCD). OCD is a chronic, debilitating condition marked by intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) aimed at reducing distress or preventing feared outcomes. Affecting 1-3% of the global population, OCD significantly impairs functioning, relationships, and quality of life. CBT, particularly Exposure and Response Prevention (ERP), is a cornerstone of OCD treatment. It helps individuals confront obsessions and resist compulsions, disrupting the cycle that maintains symptoms. Through systematic exposure to feared stimuli and prevention of habitual responses, CBT promotes anxiety habituation and cognitive restructuring.
Material and Methods: Literature was gathered via PubMed, the Clinical Handbook of Psychological Disorders edited by David H. Barlow, and references from retrieved articles.
Results: OCD is a chronic illness that markedly lowers quality of life and often co-occurs with other disorders such as depression or anxiety. CBT, especially ERP, is more effective than pharmacotherapy. Neuroimaging studies (e.g., fMRI) confirm positive changes in brain activity after CBT. Regular homework between sessions is crucial for maintaining therapeutic gains.
Conclusion: Research confirms that CBT, particularly ERP, addresses core OCD mechanisms. It modifies dysfunctional thinking and behavior, reducing symptoms and improving functioning. Exposure exercises and response prevention build coping skills and reduce compulsions and obsessions. Consistent completion of therapeutic tasks, including homework, is essential for lasting outcomes. These findings highlight CBT’s efficacy as a primary treatment for OCD.
References
Singh A, Anjankar VP, Sapkale B. Obsessive-Compulsive Disorder (OCD): A comprehensive review of diagnosis, comorbidities, and treatment approaches. Cureus. Published online November 17, 2023. doi:10.7759/cureus.48960
Foa EB. Cognitive behavioral therapy of obsessive-compulsive disorder. Dialogues in Clinical Neuroscience. 2010;12(2):199-207. doi:10.31887/dcns.2010.12.2/efoa
Młynarczyk M. Techniki pracy z zaburzeniem obsesyjno-kompulsyjnym w terapii poznawczo-behawioralnej. Acta Universitatis Lodziensis Folia Psychologica. 2018;(22):33-54. doi:10.18778/1427-969x.22.03
Obsessive-Compulsive Disorder. PubMed. Published January 1, 2024. https://pubmed.ncbi.nlm.nih.gov/31985955/
Stein DJ, Costa DLC, Lochner C, et al. Obsessive–compulsive disorder. Nature Reviews Disease Primers. 2019;5(1). doi:10.1038/s41572-019-0102-3
Całun-Nadulska P, Sikora JM. Therapy of an obsessive-compulsive disorder in a cognitive-behavioural approach. Psychiatria I Psychologia Kliniczna. 2019;19(2):210-215. doi:10.15557/pipk.2019.0021
Meyer V. Modification of expectations in cases with obsessional rituals. Behaviour Research and Therapy. 1966;4(1-2):273-280. doi:10.1016/0005-7967(66)90083-0
Dèttore D, Pozza A, Andersson G. Efficacy of Technology-delivered Cognitive Behavioural Therapy for OCD Versus Control Conditions, and in Comparison with Therapist-Administered CBT: Meta-Analysis of Randomized Controlled Trials. Cognitive Behaviour Therapy. 2015;44(3):190-211. doi:10.1080/16506073.2015.1005660
Spencer SD, Stiede JT, Wiese AD, Goodman WK, Guzick AG, Storch EA. Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder. Psychiatric Clinics of North America. 2022;46(1):167-180. doi:10.1016/j.psc.2022.10.004
Foa EB, Steketee G, Grayson JB. Imaginal and in vivo exposure: A comparison with obsessive-compulsive checkers. Behavior Therapy. 1985;16(3):292-302. doi:10.1016/s0005-7894(85)80017-4
Barlow DH. Clinical Handbook of Psychological Disorders: A Step-by-Step Treatment Manual. Guilford Publications; 2021.
Wheaton MG, Galfalvy H, Steinman SA, Wall MM, Foa EB, Simpson HB. Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well? Behaviour Research and Therapy. 2016;85:6-12. doi:10.1016/j.brat.2016.07.010
Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-Compulsive Disorder. JAMA. 2017;317(13):1358. doi:10.1001/jama.2017.2200
Torres AR, Prince MJ, Bebbington PE, et al. Obsessive-Compulsive Disorder: Prevalence, Comorbidity, Impact, and Help-Seeking in the British National Psychiatric Morbidity Survey of 2000. American Journal of Psychiatry. 2006;163(11):1978-1985. doi:10.1176/ajp.2006.163.11.1978
Simpson HB, Foa EB, Liebowitz MR, et al. Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder. JAMA Psychiatry. 2013;70(11):1190. doi:10.1001/jamapsychiatry.2013.1932
Russell EJ, Fawcett JM, Mazmanian D. Risk of Obsessive-Compulsive Disorder in Pregnant and Postpartum Women. The Journal of Clinical Psychiatry. 2013;74(04):377-385. doi:10.4088/jcp.12r07917
Albert U, De Ronchi D, Maina G, Pompili M. Suicide Risk in Obsessive-Compulsive Disorder and Exploration of Risk Factors: A Systematic Review. Current Neuropharmacology. 2018;17(8):681-696. doi:10.2174/1570159x16666180620155941
Moody TD, Morfini F, Cheng G, et al. Mechanisms of cognitive-behavioral therapy for obsessive-compulsive disorder involve robust and extensive increases in brain network connectivity. Translational Psychiatry. 2017;7(9):e1230. doi:10.1038/tp.2017.192
Kvale G, Hansen B, Björgvinsson T, et al. Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment. BMC Psychiatry. 2018;18(1). doi:10.1186/s12888-018-1887-4
Veale D, Roberts A. Obsessive-compulsive disorder. BMJ. 2014;348(apr07 6):g2183. doi:10.1136/bmj.g2183
Rapinesi, C., Kotzalidis, G. D., Ferracuti, S., Sani, G., Girardi, P., & Del Casale, A. (2019). Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review. Current Neuropharmacology, 17(8), 787–807. https://doi.org/10.2174/1570159x17666190409142555
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

